TrialPLoS neglected tropical diseases2009

First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony.

Cesar Miranda-Verastegui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.